Warning! GuruFocus detected
3 Severe warning signs
with IRX.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
InhaleRx Ltd
ISIN : AU0000179475
Description
InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper-proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.74 | |||||
Equity-to-Asset | -0.09 | |||||
Debt-to-Equity | -0.53 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 10.6 | |||||
3-Year EPS without NRI Growth Rate | 5 | |||||
3-Year FCF Growth Rate | 34.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 6.69 | |||||
9-Day RSI | 15.78 | |||||
14-Day RSI | 24.09 | |||||
3-1 Month Momentum % | 22.58 | |||||
6-1 Month Momentum % | 52 | |||||
12-1 Month Momentum % | -5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.92 | |||||
Quick Ratio | 0.92 | |||||
Cash Ratio | 0.25 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.2 | |||||
Shareholder Yield % | 2.91 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -661.2 | |||||
ROA % | -126.44 | |||||
ROIC % | -552.96 | |||||
3-Year ROIIC % | 4269.23 | |||||
ROC (Joel Greenblatt) % | -514.22 | |||||
ROCE % | -610.34 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -3.29 | |||||
EV-to-EBITDA | -3.29 | |||||
EV-to-FCF | -14.06 | |||||
Earnings Yield (Greenblatt) % | -30.44 | |||||
FCF Yield % | -9.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InhaleRx Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | |||
EPS (TTM) (A$) | -0.006 | ||
Beta | -0.48 | ||
3-Year Sharpe Ratio | -0.17 | ||
3-Year Sortino Ratio | -0.3 | ||
Volatility % | 84.74 | ||
14-Day RSI | 24.09 | ||
14-Day ATR (A$) | 0.001502 | ||
20-Day SMA (A$) | 0.03005 | ||
12-1 Month Momentum % | -5 | ||
52-Week Range (A$) | 0.018 - 0.05 | ||
Shares Outstanding (Mil) | 213.45 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
InhaleRx Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
InhaleRx Ltd Stock Events
Event | Date | Price (A$) | ||
---|---|---|---|---|
No Event Data |
InhaleRx Ltd Frequently Asked Questions
What is InhaleRx Ltd(ASX:IRX)'s stock price today?
The current price of ASX:IRX is A$0.02. The 52 week high of ASX:IRX is A$0.05 and 52 week low is A$0.02.
When is next earnings date of InhaleRx Ltd(ASX:IRX)?
The next earnings date of InhaleRx Ltd(ASX:IRX) is .
Does InhaleRx Ltd(ASX:IRX) pay dividends? If so, how much?
InhaleRx Ltd(ASX:IRX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |